Publications 2019

Adil Maarouf, Delphine Stephan, Marie-Pierre Ranjeva, Jean-Philippe Ranjeva, Jean Pelletier, et al.. High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis. Journal of Translational Medicine, 2019, 17 (1), ⟨10.1186/s12967-019-1789-3⟩. ⟨hal-02059493⟩
Giuseppina Iachetta, Annarita Falanga, Yves Molino, Maxime Masse, Françoise Jabès, et al.. gH625-liposomes as tool for pituitary adenylate cyclase-activating polypeptide brain delivery. Scientific Reports, 2019, 9 (1), ⟨10.1038/s41598-019-45137-8⟩. ⟨hal-02416027⟩
K. Varini, P. Lécorché, R. Sonnette, F. Gassiot, B. Broc, et al.. Target engagement and intracellular delivery of mono- and bivalent LDL receptor-binding peptide-cargo conjugates: Implications for the rational design of new targeted drug therapies. Journal of Controlled Release, 2019, 314, pp.141-161. ⟨10.1016/j.jconrel.2019.10.033⟩. ⟨hal-02348680⟩
Santiago Rivera, Laura García-González, Michel Khrestchatisky, Kevin Baranger. Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences, 2019, 76 (16), pp.3167-3191. ⟨10.1007/s00018-019-03178-2⟩. ⟨hal-02407337⟩
Kévin Baranger, Manuel van Gijsel-Bonnello, Delphine Stephan, Wassila Carpentier, Santiago Rivera, et al.. Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer’s Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics, 2019, ⟨10.1007/s13311-019-00754-z⟩. ⟨hal-02339537⟩
Jean-Michel Paumier, Nathalie Py, Laura García-González, Anne Bernard, Delphine Stephan, et al.. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. FASEB Journal, 2019, 33 (2), pp.2910-2927. ⟨10.1096/fj.201801076R⟩. ⟨hal-02387988⟩